531546 Sigma-AldrichSTAT3 Inhibitor XX, inS3-54 - CAS 328998-92-1 - Calbiochem
A cell permeable compound that selectively binds to STAT3 and inhibits its DNA binding activity (IC₅₀ = 13.8 µM) and reduces the expression of STAT3 dependent genes.
More>> A cell permeable compound that selectively binds to STAT3 and inhibits its DNA binding activity (IC₅₀ = 13.8 µM) and reduces the expression of STAT3 dependent genes. Less<<Sinónimos: (E)-4-(3-(4-nitrobenzylidene)-2-oxo-5-phenyl-2,3-dihydro-1H-pyrrol-1-yl)benzoic acid
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
328998-92-1 | C₂₄H₁₆N₂O₅ |
Products
Número de referencia | Embalaje | Cant./Env. | |
---|---|---|---|
5315460001 | Frasco de vidrio | 10 mg |
References | |
---|---|
References | Huang, W., et al. 2014. ACS Chem. Bio. 9, 1188. |
Product Information | |
---|---|
CAS number | 328998-92-1 |
Form | Orange powder |
Hill Formula | C₂₄H₁₆N₂O₅ |
Chemical formula | C₂₄H₁₆N₂O₅ |
Reversible | Y |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | STAT3 |
Primary Target IC<sub>50</sub> | 13.8 µ |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
5315460001 | 04055977287264 |
Documentation
STAT3 Inhibitor XX, inS3-54 - CAS 328998-92-1 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Referencias bibliográficas
Visión general referencias |
---|
Huang, W., et al. 2014. ACS Chem. Bio. 9, 1188. |
Licencias necesarias e Información técnica
Cargo |
---|
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
White Paper: Further considerations of antibody validation and usage. |